.svg)
Quick answer: HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculation using fasting insulin and fasting glucose to estimate insulin resistance. A HOMA-IR below 1.0 is generally considered optimal; values above 1.9 suggest early insulin resistance, and values above 2.9 are consistent with significant insulin resistance in most reference frameworks. Exact cut-offs vary by laboratory and population. It is one of the most widely used surrogate markers for insulin sensitivity in clinical research and practice.
What Insulin Resistance Means and Why it Matters
Insulin is a hormone produced by the pancreatic beta cells that signals cells throughout the body — particularly in muscle, fat tissue, and the liver — to absorb glucose from the bloodstream. In insulin resistance, cells become less responsive to this signal. The pancreas compensates by producing more insulin to achieve the same blood glucose effect, resulting in elevated fasting insulin levels. For a period, blood glucose may remain within the normal range despite underlying insulin resistance — which is why fasting glucose alone is a relatively insensitive early marker of metabolic dysfunction.
Over time, sustained insulin resistance increases the risk of progression to type 2 diabetes, is associated with cardiovascular disease, and is central to the pathophysiology of metabolic syndrome. Comprehensive reviews of insulin resistance biomarkers establish fasting insulin as one of the most clinically informative early markers for metabolic health assessment and cardiometabolic risk prediction. The earlier insulin resistance is identified, the greater the opportunity to address the metabolic trajectory through lifestyle, monitoring, and clinical management.
How HOMA-IR is Calculated
The formula
HOMA-IR was developed in 1985 by Matthews and colleagues as a mathematical model of the relationship between glucose and insulin in the fasting state (original HOMA model for insulin resistance). The standard formula is:
HOMA-IR = (Fasting insulin [µIU/mL] × Fasting glucose [mmol/L]) / 22.5
If glucose is measured in mg/dL (as commonly reported in the United States), the formula is adjusted to:
HOMA-IR = (Fasting insulin [µIU/mL] × Fasting glucose [mg/dL]) / 405
For example, a person with a fasting insulin of 8 µIU/mL and a fasting glucose of 90 mg/dL would have:
HOMA-IR = (8 × 90) / 405 = 720 / 405 = 1.78
This result falls in a mildly elevated range suggestive of early insulin resistance in most reference frameworks.
What each variable contributes
The numerator captures the product of two simultaneous fasting measures: the amount of insulin the pancreas is producing and the glucose level it is managing. A high insulin level alongside a normal or high glucose level indicates that more insulin than expected is required to maintain glucose regulation — the defining feature of insulin resistance. A low insulin level alongside normal glucose is the expected pattern in individuals with good insulin sensitivity.
Interpreting HOMA-IR Scores
- <1.0: Interpretation: Optimal insulin sensitivity, Clinical context: Consistent with healthy beta-cell function and cellular insulin responsiveness
- 1.0–1.9: Interpretation: Normal range; mild insulin resistance possible, Clinical context: Appropriate monitoring; metabolic risk factors should inform clinical assessment
- 1.9–2.9: Interpretation: Early insulin resistance likely, Clinical context: Metabolic health review warranted; lifestyle factors and additional biomarkers assessed
- >2.9: Interpretation: Significant insulin resistance, Clinical context: Associated with metabolic syndrome criteria; clinical evaluation indicated
Cut-off values vary across published literature and between population groups. Ethnicity, age, body composition, and menstrual cycle phase can all influence HOMA-IR independently of insulin resistance. Reference ranges vary by laboratory and individual; results should be interpreted by a qualified provider in clinical context.
What Drives HOMA-IR Higher
Adiposity, particularly visceral fat
Visceral adipose tissue (fat stored around the abdominal organs rather than subcutaneously) is metabolically active and secretes inflammatory cytokines and free fatty acids that interfere with insulin signaling in the liver and muscle (adipose tissue and insulin resistance in obesity). Individuals with central adiposity — elevated waist circumference even without a high BMI — commonly have elevated HOMA-IR relative to their body weight. This is why HOMA-IR can be elevated in individuals who appear lean if visceral fat distribution is unfavorable.
Physical inactivity
Skeletal muscle is the primary site of insulin-mediated glucose disposal — accounting for roughly 80% of postprandial glucose uptake in insulin-sensitive individuals (muscle glucose uptake and insulin signaling). Physical inactivity reduces muscle glucose transporter expression (particularly GLUT4) and reduces the rate of non-oxidative glucose disposal, which contributes to insulin resistance. Regular resistance and aerobic exercise are among the most consistently effective interventions for improving HOMA-IR.
Dietary carbohydrate and energy surplus
Chronic excess energy intake — particularly from refined carbohydrates and added sugars — drives repeated postprandial insulin surges, promotes visceral fat accumulation, and over time reduces insulin receptor sensitivity. Dietary patterns associated with lower HOMA-IR in population studies include higher fiber intake, greater adherence to Mediterranean-style eating, and lower intake of refined carbohydrates and ultra-processed foods (Mediterranean diet reduces metabolic inflammation).
Sleep disruption and circadian misalignment
Short sleep duration and poor sleep quality are associated with acute and chronic increases in insulin resistance. A single night of partial sleep deprivation can produce measurable increases in fasting insulin and HOMA-IR in controlled experimental settings (partial sleep deprivation induces insulin resistance). Shift work and circadian misalignment produce longer-term metabolic consequences through disruption of cortisol rhythms and downstream glucose metabolism.
Chronic stress and cortisol
Cortisol is a counter-regulatory hormone that raises blood glucose by stimulating gluconeogenesis in the liver and opposing insulin action in peripheral tissues. Chronically elevated cortisol — from sustained psychological stress, poor sleep, or conditions such as Cushing's syndrome — contributes to insulin resistance and elevated HOMA-IR. Fasting cortisol may be worth assessing in individuals with unexplained insulin resistance, particularly when accompanied by other features of cortisol excess.
HOMA-IR Versus Other Insulin Resistance Markers
HOMA-IR is one of several surrogate markers for insulin resistance used in clinical practice and research. Others include:
- TyG index (triglyceride-glucose index): Uses fasting triglycerides and glucose, without requiring insulin measurement. Emerging evidence suggests it may outperform HOMA-IR for predicting metabolic syndrome in certain US populations. It is simpler to calculate when insulin is not measured.
- Fasting insulin alone: A high fasting insulin value is independently informative even without full HOMA-IR calculation. A fasting insulin above 10–12 µIU/mL is commonly used as a clinical marker of concern, though cut-offs vary by laboratory.
- HbA1c and fasting glucose: Later-stage markers — glucose begins rising only after insulin resistance has been sustained long enough to impair beta-cell compensation. Normal HbA1c and glucose do not exclude insulin resistance.
Biomarkers to Assess Alongside HOMA-IR
- Fasting insulin — Required for HOMA-IR calculation; early marker of resistance
- Fasting glucose — Required for HOMA-IR; reflects hepatic glucose output
- HbA1c — Average blood glucose over 3 months; confirms or excludes frank dysglycemia
- Triglycerides — Elevated in insulin resistance; component of TyG index
- HDL-C — Inversely related to insulin resistance; low HDL is a metabolic syndrome criterion
- hs-CRP — Systemic inflammation; co-travels with insulin resistance in metabolic syndrome
Superpower's Baseline Blood Panel includes fasting glucose, HbA1c, fasting insulin, triglycerides, HDL-C, and hs-CRP — all the components needed to calculate HOMA-IR and contextualize it within the broader metabolic picture.
Frequently Asked Questions
What is a good HOMA-IR score?
A HOMA-IR below 1.0 is generally considered optimal, reflecting strong insulin sensitivity. Scores below 1.9 are within a broadly normal range in most populations, though lower is generally better for long-term metabolic health. Scores above 1.9 suggest early insulin resistance; scores above 2.9 are associated with metabolic syndrome criteria in most reference frameworks. Cut-offs vary by population and laboratory, so provider interpretation in clinical context is important.
Can HOMA-IR be normal with a high fasting glucose?
If fasting glucose is elevated but insulin is low — as in someone whose beta cells can no longer compensate — HOMA-IR may be lower than expected despite meaningful metabolic dysfunction. This is why HOMA-IR is best interpreted alongside fasting insulin and HbA1c rather than in isolation. HOMA-IR is most informative in the early and middle stages of insulin resistance, before beta-cell exhaustion occurs.
How is HOMA-IR different from a glucose tolerance test?
A glucose tolerance test (GTT) measures how the body clears a glucose load over 2 hours, providing a dynamic assessment of both insulin secretion and peripheral insulin action. HOMA-IR is a fasting measure that reflects the steady-state relationship between insulin and glucose, providing a simpler snapshot of insulin resistance without a glucose challenge. The GTT is more sensitive for detecting early type 2 diabetes, while HOMA-IR is practical for routine metabolic screening.
What fasting is required before HOMA-IR testing?
Both fasting glucose and fasting insulin should be measured after a minimum 8-hour fast (12 hours is standard for most clinical panels). Eating before the test will raise both insulin and glucose acutely, producing a falsely elevated HOMA-IR that does not reflect the resting steady-state the formula is designed to capture.
Can HOMA-IR improve with lifestyle changes?
Yes. HOMA-IR is a responsive marker that typically improves with consistent aerobic exercise, resistance training, reduction in refined carbohydrate intake, adequate sleep, and weight reduction where appropriate. Improvements can be observed within weeks to months of sustained lifestyle changes, and serial HOMA-IR testing provides objective evidence of metabolic response over time.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine. Superpower offers blood panels that include the biomarkers needed to calculate HOMA-IR. Links to individual tests are provided for informational context.
.avif)